Literature DB >> 15388334

ALS2CL, the novel protein highly homologous to the carboxy-terminal half of ALS2, binds to Rab5 and modulates endosome dynamics.

Shinji Hadano1, Asako Otomo, Kyoko Suzuki-Utsunomiya, Ryota Kunita, Yoshiko Yanagisawa, Junko Showguchi-Miyata, Hikaru Mizumura, Joh-E Ikeda.   

Abstract

ALS2, the causative gene product for juvenile recessive amyotrophic lateral sclerosis (ALS2), is a guanine-nucleotide exchange factor for the small GTPase Rab5. Here, we report a novel ALS2 homologous gene, ALS2 C-terminal like (ALS2CL), which encodes a 108-kD ALS2CL protein. ALS2CL exhibited a specific but a relatively weak Rab5-GEF activity with accompanying rather strong Rab5-binding properties. In HeLa cells, co-expression of ALS2CL and Rab5A resulted in a unique tubulation phenotype of endosome compartments with significant colocalization of ALS2CL and Rab5A. These results suggest that ALS2CL is a novel factor modulating the Rab5-mediated endosome dynamics in the cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388334     DOI: 10.1016/j.febslet.2004.07.092

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

1.  Deficiency in the ALS2 gene does not affect the motor neuron degeneration in SOD1(G93A) transgenic mice.

Authors:  Xian Lin; Hoon Shim; Huaibin Cai
Journal:  Neurobiol Aging       Date:  2006-09-12       Impact factor: 4.673

2.  Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities.

Authors:  R S Devon; P C Orban; K Gerrow; M A Barbieri; C Schwab; L P Cao; J R Helm; N Bissada; R Cruz-Aguado; T-L Davidson; J Witmer; M Metzler; C K Lam; W Tetzlaff; E M Simpson; J M McCaffery; A E El-Husseini; B R Leavitt; M R Hayden
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

3.  Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31.

Authors:  Hiroaki Kajiho; Kyoko Sakurai; Tomohiro Minoda; Manabu Yoshikawa; Satoshi Nakagawa; Shinichi Fukushima; Kenji Kontani; Toshiaki Katada
Journal:  J Biol Chem       Date:  2011-05-17       Impact factor: 5.157

4.  Loss of ALS2 function is insufficient to trigger motor neuron degeneration in knock-out mice but predisposes neurons to oxidative stress.

Authors:  Huaibin Cai; Xian Lin; Chengsong Xie; Fiona M Laird; Chen Lai; Hongjin Wen; Hsueh-Cheng Chiang; Hoon Shim; Mohamed H Farah; Ahmet Hoke; Donald L Price; Philip C Wong
Journal:  J Neurosci       Date:  2005-08-17       Impact factor: 6.167

Review 5.  Alsin and the molecular pathways of amyotrophic lateral sclerosis.

Authors:  Jayanth Chandran; Jinhui Ding; Huaibin Cai
Journal:  Mol Neurobiol       Date:  2007-07-10       Impact factor: 5.590

6.  Regulation of endosomal motility and degradation by amyotrophic lateral sclerosis 2/alsin.

Authors:  Chen Lai; Chengsong Xie; Hoon Shim; Jayanth Chandran; Brian W Howell; Huaibin Cai
Journal:  Mol Brain       Date:  2009-07-24       Impact factor: 4.041

Review 7.  Lacritin and other new proteins of the lacrimal functional unit.

Authors:  Robert L McKown; Ningning Wang; Ronald W Raab; Roy Karnati; Yinghui Zhang; Patricia B Williams; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2008-09-18       Impact factor: 3.467

Review 8.  ALS2/alsin knockout mice and motor neuron diseases.

Authors:  Huaibin Cai; Hoon Shim; Chen Lai; Chengsong Xie; Xian Lin; Wan Jou Yang; Jayanth Chandran
Journal:  Neurodegener Dis       Date:  2008-08-20       Impact factor: 2.977

9.  An interrupted beta-propeller and protein disorder: structural bioinformatics insights into the N-terminus of alsin.

Authors:  Dinesh C Soares; Paul N Barlow; David J Porteous; Rebecca S Devon
Journal:  J Mol Model       Date:  2008-11-21       Impact factor: 1.810

10.  Co-clustering phenome-genome for phenotype classification and disease gene discovery.

Authors:  TaeHyun Hwang; Gowtham Atluri; MaoQiang Xie; Sanjoy Dey; Changjin Hong; Vipin Kumar; Rui Kuang
Journal:  Nucleic Acids Res       Date:  2012-06-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.